The oral glucose tolerance test(OGTT)has been widely used both in clinics and in basic research for a long time.It is applied to diagnose impaired glucose tolerance and/or type 2 diabetes mellitus in individuals.Addit...The oral glucose tolerance test(OGTT)has been widely used both in clinics and in basic research for a long time.It is applied to diagnose impaired glucose tolerance and/or type 2 diabetes mellitus in individuals.Additionally,it has been employed in research to investigate glucose utilization and insulin sensitivity in animals.The main aim of each was quite different,and the details are also somewhat varied.However,the time or duration of the OGTT was the same,using the 2-h post-glucose load glycemia in both,following the suggestions of the American Diabetes Association.Recently,the use of 30-min or 1-h post-glucose load glycemia in clinical practice has been recommended by several studies.In this review article,we describe this new view and suggest perspectives for the OGTT.Additionally,quantification of the glucose curve in basic research is also discussed.Unlike in clinical practice,the incremental area under the curve is not suitable for use in the studies involving animals receiving repeated treatments or chronic treatment.We discuss the potential mechanisms in detail.Moreover,variations between bench and bedside in the application of the OGTT are introduced.Finally,the newly identified method for the OGTT must achieve a recommendation from the American Diabetes Association or another official unit soon.In conclusion,we summarize the recent reports regarding the OGTT and add some of our own perspectives,including machine learning and others.展开更多
Background:One-hour postprandial hyperglycemia is associated with increased risk of type 2 diabetes and cardiovascular disease.Physical activity(PA)has short-term beneficial effects on post-meal glucose response.This ...Background:One-hour postprandial hyperglycemia is associated with increased risk of type 2 diabetes and cardiovascular disease.Physical activity(PA)has short-term beneficial effects on post-meal glucose response.This study compared the oral glucose tolerance test results of 3 groups of people with habitually different levels of PA.Methods:Thirty-one adults without diabetes(age 25.9±6.6 years;body mass index 23.8±3.8 kg/m^2;mean±SD)were recruited and divided into 3 groups based on self-reported PA volume and intensity:low activity<30 min/day of moderate-intensity activity(n=11),moderately active≥30 min/day of moderate-intensity PA(n=10),and very active≥60 min/day of PA at high intensity(n=10).Participants completed an oral glucose tolerance test(50 g glucose)with capillary blood samples obtained at baseline,15 min,30 min,45 min,60 min,90 min,and 120 min post-ingestion.Results:There were no significant differences between groups for age or body fat percentage or glycated hemoglobin(p>0.05).The groups were significantly different in terms of baseline glucose level(p=0.003)and,marginally,for gender(p=0.053)and BMI(p=0.050).There was a statistically significant effect of PA on the 1-h postprandial glucose results(p=0.029),with differences between very active and low activity groups(p=0.008)but not between the moderately active and low activity groups(p=0.360),even when baseline glucose level and gender differences were accounted for.For incremental area under the curve there was no significant effect of activity group once gender and body fat percentage had been accounted for(p=0.401).Those in the low activity group took 15 min longer to reach peak glucose level than those in the very active group(p=0.012).Conclusion:The results suggest that high levels of PA have a beneficial effect on postprandial blood glucose profiles when compared to low and moderate levels of activity.展开更多
It is well known that Diabetes Specific Nutritional Supplements (DSNSs) are linked to improved glycemic control in individuals with diabetes. However, data on efficacy of DSNSs in prediabetics is limited. This was a t...It is well known that Diabetes Specific Nutritional Supplements (DSNSs) are linked to improved glycemic control in individuals with diabetes. However, data on efficacy of DSNSs in prediabetics is limited. This was a two-armed, open-labelled, randomized controlled six-week study on 199 prediabetics [30 - 65 years;Glycosylated Hemoglobin (HbA1c) 5.7% - 6.4% and/or Fasting Blood Glucose (FBG) 100-125 mg/dl]. Two parallel phases were conducted: Acute Blood Glucose Response (ABGR) and Intervention phase. Prediabetic participants were randomized into test (n = 100) and control (n = 99). The primary objective was to assess the ABGR of DSNS versus an isocaloric snack, measured by incremental Area under the Curve (iAUC). Test and control received 60 g of DSNS and 56 g of isocaloric snack (cornflakes) respectively, both in 250 ml double-toned milk on visit days 1, 15, 29 and 43. Postprandial Blood Glucose (PPG) was estimated at 30, 60, 90, 120, 150 and 180 minutes. During the 4 weeks intervention phase, the test group received DSNS with lifestyle counselling (DSNS + LC) and was compared with the control receiving lifestyle counselling alone (LC alone). Impact was studied on FBG, HbA1C, anthropometry, body composition, blood pressure, nutrient intake, and physical activity. The impact of DSNS was also studied using CGM between two 14-day phases: CGM1 baseline (days 1 - 14) and CGM2 endline (days 28 - 42). DSNS showed significantly lower PPG versus isocaloric snack at 30 (p 12, and chromium were reported by DSNS + LC versus LC alone. No other significant changes were reported between groups. It may be concluded that DSNS may be considered as a snack for prediabetic or hyperglycemic individuals requiring nutritional support for improved glycemic control.展开更多
目的探究胰岛素分泌曲线和血糖谱在2型糖尿病选择胰岛素促泌剂中的价值,为临床胰岛素促泌剂选择提供依据。方法本研究为随机对照试验,选取2015年12月至2020年12月东营市第二人民医院根据降糖治疗需要选用胰岛素促泌剂的2型糖尿病患者12...目的探究胰岛素分泌曲线和血糖谱在2型糖尿病选择胰岛素促泌剂中的价值,为临床胰岛素促泌剂选择提供依据。方法本研究为随机对照试验,选取2015年12月至2020年12月东营市第二人民医院根据降糖治疗需要选用胰岛素促泌剂的2型糖尿病患者120例作为研究对象,采用随机数字表法分为观察组和对照组,各60例。观察组男38例、女22例,年龄(58.27±6.34)岁,病程(3.62±1.28)年;对照组男33例、女27例,年龄(59.04±7.82)岁,病程(3.55±1.17)年。观察组进行馒头餐试验并依据胰岛素分泌曲线选择胰岛素促泌剂;对照组依据血糖谱选择胰岛素促泌剂,两组均治疗24周。对比两组患者血糖控制达标平均天数、血糖达标率、住院天数、低血糖发生率及治疗前后胰岛素β细胞功能[空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、C肽(CP)水平]、血糖[空腹血糖(FPG)、餐后2 h血糖(2 h PBG)、糖化血红蛋白(HbA1c)]水平、不良反应发生情况。采用t检验、χ^(2)检验。结果观察组血糖控制达标平均天数、住院天数均短于对照组[(7.05±1.42)d比(8.39±1.86)d、(10.29±2.08)d比(11.35±2.17)d],血糖达标率高于对照组[86.67%(52/60)比71.67%(43/60)],差异均有统计学意义(t=4.436、2.732,χ^(2)=4.093;均P<0.05)。治疗后,观察组FINS、CP水平均高于对照组[(9.32±1.55)IU/L比(8.46±1.38)IU/L、(1.49±0.39)μg/L比(1.35±0.32)μg/L],HOMA-IR低于对照组[(1.92±0.43)比(2.37±0.84)],差异均有统计学意义(t=3.210、2.150、3.694,均P<0.05)。治疗后,观察组FPG、2 h PBG、HbA1c水平均低于对照组[(6.47±1.12)mmol/L比(7.35±0.94)mmol/L、(10.52±1.17)mmol/L比(11.83±1.59)mmol/L、(6.12±1.09)%比(6.79±1.35)%],差异均有统计学意义(t=4.662、5.140、2.991,均P<0.05)。观察组不良反应发生率为15.00%(9/60),与对照组[18.33%(11/60)]比较,差异无统计学意义(χ^(2)=0.240,P=0.624)。结论与血糖谱相比,经胰岛素分泌曲线选择胰岛素促泌剂具有较好的促胰岛素分泌效果和降糖效果,有利于缩短血糖控制达标时间和住院时间,提高血糖达标率。展开更多
文摘The oral glucose tolerance test(OGTT)has been widely used both in clinics and in basic research for a long time.It is applied to diagnose impaired glucose tolerance and/or type 2 diabetes mellitus in individuals.Additionally,it has been employed in research to investigate glucose utilization and insulin sensitivity in animals.The main aim of each was quite different,and the details are also somewhat varied.However,the time or duration of the OGTT was the same,using the 2-h post-glucose load glycemia in both,following the suggestions of the American Diabetes Association.Recently,the use of 30-min or 1-h post-glucose load glycemia in clinical practice has been recommended by several studies.In this review article,we describe this new view and suggest perspectives for the OGTT.Additionally,quantification of the glucose curve in basic research is also discussed.Unlike in clinical practice,the incremental area under the curve is not suitable for use in the studies involving animals receiving repeated treatments or chronic treatment.We discuss the potential mechanisms in detail.Moreover,variations between bench and bedside in the application of the OGTT are introduced.Finally,the newly identified method for the OGTT must achieve a recommendation from the American Diabetes Association or another official unit soon.In conclusion,we summarize the recent reports regarding the OGTT and add some of our own perspectives,including machine learning and others.
文摘Background:One-hour postprandial hyperglycemia is associated with increased risk of type 2 diabetes and cardiovascular disease.Physical activity(PA)has short-term beneficial effects on post-meal glucose response.This study compared the oral glucose tolerance test results of 3 groups of people with habitually different levels of PA.Methods:Thirty-one adults without diabetes(age 25.9±6.6 years;body mass index 23.8±3.8 kg/m^2;mean±SD)were recruited and divided into 3 groups based on self-reported PA volume and intensity:low activity<30 min/day of moderate-intensity activity(n=11),moderately active≥30 min/day of moderate-intensity PA(n=10),and very active≥60 min/day of PA at high intensity(n=10).Participants completed an oral glucose tolerance test(50 g glucose)with capillary blood samples obtained at baseline,15 min,30 min,45 min,60 min,90 min,and 120 min post-ingestion.Results:There were no significant differences between groups for age or body fat percentage or glycated hemoglobin(p>0.05).The groups were significantly different in terms of baseline glucose level(p=0.003)and,marginally,for gender(p=0.053)and BMI(p=0.050).There was a statistically significant effect of PA on the 1-h postprandial glucose results(p=0.029),with differences between very active and low activity groups(p=0.008)but not between the moderately active and low activity groups(p=0.360),even when baseline glucose level and gender differences were accounted for.For incremental area under the curve there was no significant effect of activity group once gender and body fat percentage had been accounted for(p=0.401).Those in the low activity group took 15 min longer to reach peak glucose level than those in the very active group(p=0.012).Conclusion:The results suggest that high levels of PA have a beneficial effect on postprandial blood glucose profiles when compared to low and moderate levels of activity.
文摘It is well known that Diabetes Specific Nutritional Supplements (DSNSs) are linked to improved glycemic control in individuals with diabetes. However, data on efficacy of DSNSs in prediabetics is limited. This was a two-armed, open-labelled, randomized controlled six-week study on 199 prediabetics [30 - 65 years;Glycosylated Hemoglobin (HbA1c) 5.7% - 6.4% and/or Fasting Blood Glucose (FBG) 100-125 mg/dl]. Two parallel phases were conducted: Acute Blood Glucose Response (ABGR) and Intervention phase. Prediabetic participants were randomized into test (n = 100) and control (n = 99). The primary objective was to assess the ABGR of DSNS versus an isocaloric snack, measured by incremental Area under the Curve (iAUC). Test and control received 60 g of DSNS and 56 g of isocaloric snack (cornflakes) respectively, both in 250 ml double-toned milk on visit days 1, 15, 29 and 43. Postprandial Blood Glucose (PPG) was estimated at 30, 60, 90, 120, 150 and 180 minutes. During the 4 weeks intervention phase, the test group received DSNS with lifestyle counselling (DSNS + LC) and was compared with the control receiving lifestyle counselling alone (LC alone). Impact was studied on FBG, HbA1C, anthropometry, body composition, blood pressure, nutrient intake, and physical activity. The impact of DSNS was also studied using CGM between two 14-day phases: CGM1 baseline (days 1 - 14) and CGM2 endline (days 28 - 42). DSNS showed significantly lower PPG versus isocaloric snack at 30 (p 12, and chromium were reported by DSNS + LC versus LC alone. No other significant changes were reported between groups. It may be concluded that DSNS may be considered as a snack for prediabetic or hyperglycemic individuals requiring nutritional support for improved glycemic control.
文摘目的探究胰岛素分泌曲线和血糖谱在2型糖尿病选择胰岛素促泌剂中的价值,为临床胰岛素促泌剂选择提供依据。方法本研究为随机对照试验,选取2015年12月至2020年12月东营市第二人民医院根据降糖治疗需要选用胰岛素促泌剂的2型糖尿病患者120例作为研究对象,采用随机数字表法分为观察组和对照组,各60例。观察组男38例、女22例,年龄(58.27±6.34)岁,病程(3.62±1.28)年;对照组男33例、女27例,年龄(59.04±7.82)岁,病程(3.55±1.17)年。观察组进行馒头餐试验并依据胰岛素分泌曲线选择胰岛素促泌剂;对照组依据血糖谱选择胰岛素促泌剂,两组均治疗24周。对比两组患者血糖控制达标平均天数、血糖达标率、住院天数、低血糖发生率及治疗前后胰岛素β细胞功能[空腹胰岛素(FINS)、胰岛素抵抗指数(HOMA-IR)、C肽(CP)水平]、血糖[空腹血糖(FPG)、餐后2 h血糖(2 h PBG)、糖化血红蛋白(HbA1c)]水平、不良反应发生情况。采用t检验、χ^(2)检验。结果观察组血糖控制达标平均天数、住院天数均短于对照组[(7.05±1.42)d比(8.39±1.86)d、(10.29±2.08)d比(11.35±2.17)d],血糖达标率高于对照组[86.67%(52/60)比71.67%(43/60)],差异均有统计学意义(t=4.436、2.732,χ^(2)=4.093;均P<0.05)。治疗后,观察组FINS、CP水平均高于对照组[(9.32±1.55)IU/L比(8.46±1.38)IU/L、(1.49±0.39)μg/L比(1.35±0.32)μg/L],HOMA-IR低于对照组[(1.92±0.43)比(2.37±0.84)],差异均有统计学意义(t=3.210、2.150、3.694,均P<0.05)。治疗后,观察组FPG、2 h PBG、HbA1c水平均低于对照组[(6.47±1.12)mmol/L比(7.35±0.94)mmol/L、(10.52±1.17)mmol/L比(11.83±1.59)mmol/L、(6.12±1.09)%比(6.79±1.35)%],差异均有统计学意义(t=4.662、5.140、2.991,均P<0.05)。观察组不良反应发生率为15.00%(9/60),与对照组[18.33%(11/60)]比较,差异无统计学意义(χ^(2)=0.240,P=0.624)。结论与血糖谱相比,经胰岛素分泌曲线选择胰岛素促泌剂具有较好的促胰岛素分泌效果和降糖效果,有利于缩短血糖控制达标时间和住院时间,提高血糖达标率。
